Volume 12, Number 6—June 2006
Research
Temple Monkeys and Health Implications of Commensalism, Kathmandu, Nepal
Table 2
Characteristic | n | RhCMV (% ELISA-reactive) | SV40 (% EIA-reactive) | CHV-1 (% ELISA-reactive) | SFV (% WB-reactive) |
---|---|---|---|---|---|
Male | 17 | 94.1 | 94.1 | 64.7 | 94.1 |
Female | 22 | 95.5 | 86.4 | 63.6 | 100.0 |
Juvenile | 13 | 84.6 | 76.9 | 23.1 | 92.3 |
Subadult | 7 | 100.0 | 100.0 | 42.9 | 100.0 |
Adult | 19 | 100.0 | 94.7 | 100.0 | 100.0 |
Total | 39 | 94.9 | 89.7 | 64.1 | 97.4 |
*RhCMV, rhesus cytomegalovirus; ELISA, enzyme-linked immunosorbent assay; SV40, simian virus 40; EIA, enzyme immunoassay; CHV-1, cercopithecine herpesvirus 1; SFV, simian foamy virus; WB, Western blot.
†Seven samples were ELISA-positive for simian retrovirus (SRV); 4 of these were indeterminate on WB, and 3 were negative. Polymerase chain reaction (PCR) failed to amplify SRV from any sample. Nine samples were ELISA-positive for simian T-cell lymphotropic virus (STLV), but none were positive on immunoblot, and nested PCR detected no STLV DNA. None of the samples was reactive to simian immunodeficiency virus.
Page created: January 04, 2012
Page updated: January 04, 2012
Page reviewed: January 04, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.